Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial.
Sekimizu M, Osumi T, Fukano R, Koga Y, Kada A, Saito AM, Mori T. Sekimizu M, et al. Among authors: saito am. Acta Med Okayama. 2018 Aug;72(4):431-436. doi: 10.18926/AMO/56184. Acta Med Okayama. 2018. PMID: 30140094 Free article.
Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature.
Sekimizu M, Sunami S, Nakazawa A, Hayashi Y, Okimoto Y, Saito AM, Horibe K, Tsurusawa M, Mori T. Sekimizu M, et al. Among authors: saito am. Br J Haematol. 2011 Sep;154(5):612-7. doi: 10.1111/j.1365-2141.2011.08788.x. Epub 2011 Jun 21. Br J Haematol. 2011. PMID: 21689091 Free article.
Improved treatment results of children with B-cell non-Hodgkin lymphoma: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study.
Tsurusawa M, Mori T, Kikuchi A, Mitsui T, Sunami S, Kobayashi R, Takimoto T, Saito A, Watanabe T, Fujimoto J, Nakazawa A, Ohshima K, Horibe K; lymphoma committee of Japanese Pediatric Leukemia/Lymphoma Study Group. Tsurusawa M, et al. Pediatr Blood Cancer. 2014 Jul;61(7):1215-21. doi: 10.1002/pbc.24975. Epub 2014 Feb 13. Pediatr Blood Cancer. 2014. PMID: 24523211 Clinical Trial.
Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
Tsurusawa M, Gosho M, Mori T, Mitsui T, Sunami S, Kobayashi R, Fukano R, Tanaka F, Fujita N, Inada H, Koh K, Takimoto T, Saito A, Fujimoto J, Nakazawa A, Horibe K; lymphoma committee of the Japanese Pediatric Leukemia/lymphoma Study Group. Tsurusawa M, et al. Pediatr Blood Cancer. 2015 Feb;62(2):279-284. doi: 10.1002/pbc.25305. Epub 2014 Oct 30. Pediatr Blood Cancer. 2015. PMID: 25359701
Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
Sekimizu M, Mori T, Kikuchi A, Mitsui T, Sunami S, Kobayashi R, Fujita N, Inada H, Takimoto T, Saito AM, Watanabe T, Fujimoto J, Nakazawa A, Ohshima K, Horibe K, Tsurusawa M; Lymphoma Committee of the Japanese Pediatric Leukemia/Lymphoma Study Group. Sekimizu M, et al. Among authors: saito am. Pediatr Blood Cancer. 2015 Jul;62(7):1294-6. doi: 10.1002/pbc.25482. Epub 2015 Mar 19. Pediatr Blood Cancer. 2015. PMID: 25790170
Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Sunami S, Sekimizu M, Takimoto T, Mori T, Mitsui T, Fukano R, Saito AM, Watanabe T, Ohshima K, Fujimoto J, Nakazawa A, Kobayashi R, Horibe K, Tsurusawa M. Sunami S, et al. Among authors: saito am. Pediatr Blood Cancer. 2016 Mar;63(3):451-7. doi: 10.1002/pbc.25824. Epub 2015 Nov 19. Pediatr Blood Cancer. 2016. PMID: 26585702
Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia/lymphoma study group B-NHL03 study.
Tsurusawa M, Watanabe T, Gosho M, Mori T, Mitsui T, Sunami S, Kobayashi R, Fukano R, Tanaka F, Fujita N, Inada H, Sekimizu M, Koh K, Kosaka Y, Komada Y, Saito AM, Nakazawa A, Horibe K; lymphoma committee of the Japanese Pediatric Leukemia/lymphoma Study Group. Tsurusawa M, et al. Among authors: saito am. Leuk Lymphoma. 2016 Jul;57(7):1657-64. doi: 10.3109/10428194.2015.1106534. Epub 2015 Dec 23. Leuk Lymphoma. 2016. PMID: 26694130 Clinical Trial.
Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Fukano R, Sunami S, Sekimizu M, Takimoto T, Mori T, Mitsui T, Mori T, Saito AM, Watanabe T, Ohshima K, Fujimoto J, Nakazawa A, Kiyokawa N, Kobayashi R, Horibe K, Tsurusawa M. Fukano R, et al. Among authors: saito am. J Pediatr Hematol Oncol. 2018 Jan;40(1):e34-e37. doi: 10.1097/MPH.0000000000000850. J Pediatr Hematol Oncol. 2018. PMID: 28538509
161 results